Growth Metrics

Ardelyx (ARDX) Cash from Investing Activities (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -364.70%
Dec 31, 2025 107.48%
Sep 30, 2025 -244.63%
Jun 30, 2025 1,124.94%
Mar 31, 2025 106.85%
Dec 31, 2024 -1,877.87%
Sep 30, 2024 -90.05%
Jun 30, 2024 1,014.97%
Mar 31, 2024 91.30%
Dec 31, 2023 9.57%
Sep 30, 2023 44.78%
Jun 30, 2023 -505.57%
Mar 31, 2023 -778.49%
Dec 31, 2022 273.20%
Sep 30, 2022 -105.38%
Jun 30, 2022 563.55%
Mar 31, 2022 -89.45%
Dec 31, 2021 21.86%
Sep 30, 2021 120.22%
Jun 30, 2021 231.35%
Mar 31, 2021 169.61%
Dec 31, 2020 -137.21%
Sep 30, 2020 -28.49%
Jun 30, 2020 126.37%
Mar 31, 2020 8.25%
Dec 31, 2019 -336.53%
Sep 30, 2019 -7.70%
Jun 30, 2019 -15.26%
Mar 31, 2019 35.11%
Dec 31, 2018 119.88%
Sep 30, 2018 116.53%
Jun 30, 2018 -5,278.06%
Mar 31, 2018 -110.11%
Dec 31, 2017 -24.22%
Sep 30, 2017 -9.11%
Jun 30, 2017 -29.06%
Mar 31, 2017 138.78%
Dec 31, 2016 16.99%
Sep 30, 2016 -24,087.46%
Jun 30, 2016 -47.50%
Mar 31, 2016 55.95%
Dec 31, 2015 33.24%
Sep 30, 2015 46.25%
Jun 30, 2015 -19.91%
Mar 31, 2015 -2.23%
Dec 31, 2014 -1,072.73%
Sep 30, 2014 86.29%
Jun 30, 2014 -582.98%